🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05192759
Recruiting Not applicable

Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait

NCT05192759 · tracked via the Priya Life Science China tracker
Sponsor
Anhui Medical University
Phase
Not applicable
Started
2021-11-22
Last updated
2025-11-19

Condition(s) studied

Transcranial Magnetic StimulationFreezing of Gait

Investigational drug(s) / intervention(s)

Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation: The stimulations were performed by MagStim Rapid2.

Study summary

To investigate the treatment effect of Theta-burst Transcranial Magnetic Stimulation (TBS) on patients with freezing of gait (FOG) and the underlying neural mechanism.

Eligibility

Sex
ALL
Min age
40 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. diagnosis of FOG with expertise in movement disorders. 2. the score of item 3 of the FOG questionnaire ≥1. 3. ongoing treatment with a stable dose of any medication for 2 months. 4. 40 years of age or older. Exclusion Criteria: 1. a history of addiction, psychiatric disorders, or neurological diseases other than PD. 2. focal brain lesions on T1-/T2-weighted fluid-attenuated inversion recovery images. 3. anti-PD medication adjustments during rTMS treatment. 4. history of substance abuse within the past 6 months. 5. nonremovable metal objects in or around the head. 6. previously received rTMS treatment. 7. prior history of seizure or history in first-degree relatives.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cognitive Neuropsychology Lab Anhui Medical University Hefei Anhui Recruiting

More Anhui Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05192759 on ClinicalTrials.gov ↗ ← All trials in China